Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.

Benzinger A, Muster N, Koch HB, Yates JR 3rd, Hermeking H.

Mol Cell Proteomics. 2005 Jun;4(6):785-95. Epub 2005 Mar 18.

PMID:
15778465
[PubMed - indexed for MEDLINE]
Free Article
2.

Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2.

Dhar G, Banerjee S, Dhar K, Tawfik O, Mayo MS, Vanveldhuizen PJ, Banerjee SK.

Cancer Res. 2008 Jun 15;68(12):4580-7. doi: 10.1158/0008-5472.CAN-08-0316.

PMID:
18559502
[PubMed - indexed for MEDLINE]
Free Article
3.

Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest.

Wang X, Li N, Li H, Liu B, Qiu J, Chen T, Cao X.

Clin Cancer Res. 2005 Oct 15;11(20):7545-53.

PMID:
16243830
[PubMed - indexed for MEDLINE]
Free Article
4.

EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53.

Kapoor GS, Christie A, O'Rourke DM.

Cancer Biol Ther. 2007 Apr;6(4):571-9.

PMID:
17457042
[PubMed - indexed for MEDLINE]
Free Article
5.

Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.

Bon G, Di Carlo SE, Folgiero V, Avetrani P, Lazzari C, D'Orazi G, Brizzi MF, Sacchi A, Soddu S, Blandino G, Mottolese M, Falcioni R.

Cancer Res. 2009 Jul 15;69(14):5978-86. doi: 10.1158/0008-5472.CAN-09-0244. Epub 2009 Jun 30.

PMID:
19567674
[PubMed - indexed for MEDLINE]
Free Article
6.

Chmp1A functions as a novel tumor suppressor gene in human embryonic kidney and ductal pancreatic tumor cells.

Li J, Belogortseva N, Porter D, Park M.

Cell Cycle. 2008 Sep 15;7(18):2886-93. Epub 2008 Sep 26.

PMID:
18787405
[PubMed - indexed for MEDLINE]
Free Article
7.

DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.

Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, Qiu Y, Diaz J, Laronga C, Lee MH.

Cancer Res. 2006 Mar 15;66(6):3096-105.

PMID:
16540659
[PubMed - indexed for MEDLINE]
Free Article
8.

Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.

Kasiappan R, Shih HJ, Chu KL, Chen WT, Liu HP, Huang SF, Choy CO, Shu CL, Din R, Chu JS, Hsu HL.

Mol Cancer Res. 2009 Apr;7(4):536-48. doi: 10.1158/1541-7786.MCR-08-0422.

PMID:
19372582
[PubMed - indexed for MEDLINE]
Free Article
9.

FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells.

Martin BT, Kleiber K, Wixler V, Raab M, Zimmer B, Kaufmann M, Strebhardt K.

Cell Cycle. 2007 Jul 15;6(14):1779-88.

PMID:
17682292
[PubMed - indexed for MEDLINE]
Free Article
10.

TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.

Lim IK.

J Cancer Res Clin Oncol. 2006 Jul;132(7):417-26. Epub 2006 Feb 3. Review.

PMID:
16456675
[PubMed - indexed for MEDLINE]
11.

Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells.

Rehman A, Chahal MS, Tang X, Bruce JE, Pommier Y, Daoud SS.

Breast Cancer Res. 2005;7(5):R765-74. Epub 2005 Jul 27.

PMID:
16168122
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses.

Lee JH, Byun DS, Lee MG, Ryu BK, Kang MJ, Chae KS, Lee KY, Kim HJ, Park H, Chi SG.

Int J Cancer. 2008 Apr 1;122(7):1573-84.

PMID:
18059034
[PubMed - indexed for MEDLINE]
13.

Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.

Choi HJ, Chung TW, Kang SK, Lee YC, Ko JH, Kim JG, Kim CH.

Glycobiology. 2006 Jul;16(7):573-83. Epub 2006 Mar 30.

PMID:
16574813
[PubMed - indexed for MEDLINE]
Free Article
14.

Radiation response and cell cycle regulation of p53 rescued malignant keratinocytes.

Niemantsverdriet M, Jongmans W, Backendorf C.

Exp Cell Res. 2005 Oct 15;310(1):237-47.

PMID:
16120440
[PubMed - indexed for MEDLINE]
15.

Epigenetic silencing of 14-3-3sigma in cancer.

Lodygin D, Hermeking H.

Semin Cancer Biol. 2006 Jun;16(3):214-24. Epub 2006 Apr 1. Review.

PMID:
16698281
[PubMed - indexed for MEDLINE]
16.

Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility.

Xia M, Land H.

Nat Struct Mol Biol. 2007 Mar;14(3):215-23. Epub 2007 Feb 18.

PMID:
17310253
[PubMed - indexed for MEDLINE]
17.

Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines.

Crea F, Giovannetti E, Cortesi F, Mey V, Nannizzi S, Gallegos Ruiz MI, Ricciardi S, Del Tacca M, Peters GJ, Danesi R.

Mol Cancer Ther. 2009 Jul;8(7):1964-73. doi: 10.1158/1535-7163.MCT-09-0027. Epub 2009 Jun 16.

PMID:
19531575
[PubMed - indexed for MEDLINE]
Free Article
18.

PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway.

Yu DH, Fan W, Liu G, Nguy V, Chatterton JE, Long S, Ke N, Meyhack B, Bruengger A, Brachat A, Wong-Staal F, Li QX.

Exp Cell Res. 2006 Apr 1;312(6):865-76. Epub 2006 Jan 17.

PMID:
16413018
[PubMed - indexed for MEDLINE]
19.

p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints.

Wang S, El-Deiry WS.

Cancer Res. 2006 Jul 15;66(14):6982-9.

PMID:
16849542
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk